Focal Cryoablation for Prostate Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
To learn if using cryotherapy to treat only the part of the prostate known to contain cancer is effective in controlling prostate cancer
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators or your doctor for guidance.
Is focal cryoablation for prostate cancer safe?
How does the treatment Focal Cryoablation differ from other treatments for prostate cancer?
What data supports the effectiveness of the treatment Focal Cryoablation for Prostate Cancer?
Who Is on the Research Team?
Justin Gregg, MD
Principal Investigator
jrgregg@mdanderson.org
Are You a Good Fit for This Trial?
Men with intermediate-risk prostate cancer who have a single focus of disease visible on MRI and confirmed by biopsy, without evidence of spread beyond the prostate. They must be able to undergo MRI, have not had previous treatments for prostate cancer or certain prostate surgeries, and are willing to follow study procedures.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo focal cryotherapy ablation targeting the prostate cancer site
Follow-up
Participants are monitored for safety, effectiveness, and quality of life post-treatment
Long-term follow-up
Participants are monitored for progression and re-intervention as part of standard care
What Are the Treatments Tested in This Trial?
Interventions
- Focal Cryoablation
- Standard of Care
Focal Cryoablation is already approved in European Union, United States, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Philanthropic Sources
Collaborator